Your browser doesn't support javascript.
loading
Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial.
Starling, Amaal J; Cowan, Robert P; Buse, Dawn C; Diener, Hans-Christoph; Marmura, Michael J; Hirman, Joe; Brevig, Thomas; Cady, Roger.
Afiliação
  • Starling AJ; Mayo Clinic, Scottsdale, Arizona, USA.
  • Cowan RP; Department of Neurology and Neurological Sciences, Stanford University Headache and Facial Pain Program, Palo Alto, California, USA.
  • Buse DC; Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Diener HC; Vector Psychometric Group, LLC, Chapel Hill, North Carolina, USA.
  • Marmura MJ; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty of the University Duisburg-Essen, Essen, Germany.
  • Hirman J; Jefferson Headache Center, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, USA.
  • Brevig T; Pacific Northwest Statistical Consulting, Inc., Woodinville, WA, USA.
  • Cady R; H. Lundbeck A/S, Copenhagen, Denmark.
Headache ; 63(2): 264-274, 2023 02.
Article em En | MEDLINE | ID: mdl-36633219
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos da Cefaleia Secundários / Transtornos de Enxaqueca Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos da Cefaleia Secundários / Transtornos de Enxaqueca Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article